MAPK3 and pancreatic neoplasm: Gefinitib also inhibited the phosphoylation of EGFR, Src, AKT, and ERK1/2 pathway, and furthermore pretreatment of gefinitib diminished the effect of kaempferol on migration of pancreatic cancer cells.